BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:Central Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:Central Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250729T100000
DTEND;TZID=America/Chicago:20250729T110000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:The Future of Cancer Screening: MCED Updates from GRAIL
DESCRIPTION:Join GRAIL for an exciting conversation about advancements in multi-cancer early detection. We will provide updates on our clinical validation program\, including positive top-line performance and safety results from the PATHFINDER 2 trial\, as well as review the latest efforts to establish timely\, equitable access with policymakers.\n\nThis briefing is not intended for members of the media.  If you are a member of the press\, we kindly ask that you contact our communications team.
X-ALT-DESC;FMTTYPE=text/html:Join GRAIL for an exciting conversation about advancements in multi-cancer early detection. We will provide updates on our clinical validation program\, including positive top-line performance and safety results from the PATHFINDER 2 trial\, as well as review the latest efforts to establish timely\, equitable access with policymakers.\n\nThis briefing is not intended for members of the media.  If you are a member of the press\, we kindly ask that you contact our communications team.
LOCATION:
UID:e.3812.1233965
SEQUENCE:3
DTSTAMP:20260503T115820Z
URL:https://biontx.growthzoneapp.com/biontx-event-calendar/Details/the-future-of-cancer-screening-mced-updates-from-grail-1441517?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR